DIVI'S LABORATORIES

World Rank (Jul-30-2023)
1,438
Market Cap (Jul-30-2023)
12.07 Billion USD
World Rank (Dec-25-2022)
1,422
Market Cap (Dec-25-2022)
11.00 Billion USD
World Rank (Jan-07-2022)
1,265
Market Cap (Jan-07-2022)
16.053 Billion USD
World Rank (Jan-01-2021)
1,260
Market Cap (Jan-01-2021)
13.982 Billion USD
Annual Revenue in USD
944 Million USD
Annual Net Income in USD
222 Million USD
Total Assets in USD
1,755 Million USD
Total Liabilities in USD
203 Million USD
Annual Results for Year ending in
Mar-2023 month
Headquarters State / City
Hyderabad
Headquarters Country
India
Headquarters Sub Region
Southern Asia
Headquarters Continent
Asia
Company Business
Healthcare
HealthCare Products
Pharmaceutical
Stock Category
Nifty 50 Index
BSE-100 Index
S&P BSE HEALTH CARE
Stock Exchange
BSE
NSE
Company Rank in Country in 2022
Company Rank in India in 2022 is 47
Rank in Country (Jan-2021)
Company Rank in India in 2021 is 31
Rank in Country (Jan-2020)
Rank in India in 2020 is 67
Number of Employees
13,884
Employee Count as on Date
As on March 2020
ISIN Code:
INE361B01024
Chairman
Divi Murali
Billionaires related to Enterprise:
Nilima Motaparti
Divi Satchandra Kiran
Yahoo @ BSE
Wikipedia
MoneyControl
Company Website:
Divis Laboratories Limited
Business Sector:
Top Healthcare Companies in India
Top Pharmaceutical Companies in India
About Company Business:

DIVI'S LABORATORIES is Pharmaceutical company with headquarters in Hyderabad, India.

Facts About Company

Divi's Laboratories annual revenues for FY 2023 is 7,767 Crores.

As on March-2020, Divi's Laboratories has 13,884 employees.

Founded Year
1990
Annual Results Summary:

DIVI'S LABORATORIES - Annual Results - Consolidated - Revenue and Net Profits- in Crores INR:

Year - Ending Revenue Net Income EPS (INR)
Mar-2023 7,767 1,823 68.69
Mar-2022 8,959 2,960 111.52
Mar-2021 6,969 1,984 74.75
Mar-2020 5,394 1,376 51.85
Mar-2019 4,946 1,353 50.96
Mar-2018 3,913  877 33.04
Mar-2017 4,106 1,060 39.95
Mar-2016 3,805 1,126 42.41
Quarterly Results Summary:

DIVI'S LABORATORIES - Consolidated- Quarterly Results - in Crores INR

QUARTER ENDED TOTAL INCOME NET PROFIT EPS (INR)
Sep-2022 1,854 493 18.60
Jun-2022 2,254 702 26.44
Mar-2022 2,518  894 33.70
Dec-2021 2,493 902 33.99
Sep-2021 1,987 606 22.84
Jun-2021 1,950 552 20.79
Mar-2021 1,718 488 18.38
Dec-2020 1,656 461 17.37
Sep-2020 1,713 513 19.34
Jun-2020 1,710 492 18.54
Mar-2020 1,376 392 14.76
Dec-2019 1,390 360 13.59
Sep-2019 1,404 352 13.29

Comments

Divi's Laboratories Sep 2020 ending quarter highlights

Quarterly Revenues of Divi's Laboratories (Consolidated):

Divi's Laboratoris Revenue from operations (Consolidated) in Sep 2020 ending quarter is 1,762.94 Crores INR.

Divi's Laboratoris Revenue from operations (Consolidated) in Sep 2019 ending quarter is 1,445.57 Crores INR.

Divi's Laboratoris Revenue from operations (Consolidated) in Jun 2020 ending quarter is 1,730.47 Crores INR.

Quarterly Net Profit of Divi's Laboratories (Consolidated):

Divi's Laboratoris Net Profit from operations (Consolidated) in Sep 2020 ending quarter is 519.59 Crores INR.

Divi's Laboratoris Net Profit from operations (Consolidated) in Sep 2019 ending quarter is 356.78 Crores INR.

Divi's Laboratoris Net Profit from operations (Consolidated) in Jun 2020 ending quarter is 492.06 Crores INR.

Quarterly EPS of Divi's Laboratories (Consolidated):

Divi's Laboratoris EPS from operations (Consolidated) in Sep 2020 ending quarter is 19.57 INR.

Divi's Laboratoris EPS from operations (Consolidated) in Sep 2019 ending quarter is 13.44 INR.

Divi's Laboratoris EPS from operations (Consolidated) in Jun 2020 ending quarter is 18.54 INR.

  • Profit before Tax (PBT) for the quarter grew by 42% to Rs. 693 crores as against a PBT of Rs.488 crores for the corresponding quarter of the last year.
  • Profit after Tax (PAT) for the quarter grew by 46% to Rs. 520 crores as against a PAT of Rs.357 crores for the corresponding quarter of the last year.
Sat, 07/11/2020 - 15:46

Share it on Social Media